Stay updated on Magrolimab Combo in Untreated MDS: Clinical Trial
Sign up to get notified when there's something new on the Magrolimab Combo in Untreated MDS: Clinical Trial page.

Latest updates to the Magrolimab Combo in Untreated MDS: Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedA site-wide NIH banner announces a transition from using “Artificial Intelligence” to “Super Intelligence.” The site revision changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe footer’s site revision changes from v3.7.0 to v3.7.1 while the page remains an access-denied error.SummaryDifference0.2%

- Check40 days agoChange DetectedThe study page now shows a 403 Forbidden page with a minimal header and footer, indicating access to the study record is blocked. This replaces the previously visible study details.SummaryDifference17%

- Check47 days agoChange DetectedThe page revision was updated from v3.6.6 to v3.7.0, indicating a newer release of the page template or rendering component.SummaryDifference0.0%

- Check61 days agoChange DetectedThe page revision label updated from v3.6.5 to v3.6.6, representing a minor update to the listing.SummaryDifference0.0%

- Check82 days agoChange DetectedRevision tag updated from v3.6.4 to v3.6.5. This reflects a small version change and does not affect the page's content about the study.SummaryDifference0.0%

Stay in the know with updates to Magrolimab Combo in Untreated MDS: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Magrolimab Combo in Untreated MDS: Clinical Trial page.